BRIEF-Wuhan YZY Biopharma Sees Decrease In Consolidated Loss By No Less Than 35% For Year

Reuters
25 Mar
BRIEF-Wuhan YZY Biopharma Sees Decrease In Consolidated Loss By No Less Than 35% For Year

March 24 (Reuters) - Wuhan YZY Biopharma Co Ltd 2496.HK:

  • EXPECTED DECREASE IN CONSOLIDATED LOSS BY NO LESS THAN 35% FOR YEAR

  • REDUCTION IN LOSS ATTRIBUTED TO LICENSE AGREEMENT AND LOWER EXPENSES IN FY

Further company coverage: 2496.HK

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10